Long-Term Outcome of Adjunctive Celecoxib Treatment After Paclitaxel-Eluting Stent Implantation for the Complex Coronary Lesions | Zendy

Jin-Wook Chung | Zendy; HanMo Yang | Zendy; Kyung Woo Park | Zendy; HaeYoung Lee | Zendy; JinShik Park | Zendy; HyunJae Kang | Zendy; YoungSeok Cho | Zendy; TaeJin Youn | Zendy; BonKwon Koo | Zendy; InHo Chae | Zendy; DongJu Choi | Zendy; ByungHee Oh | Zendy; Young-Bae Park | Zendy; Hyo-Soo Kim | Zendy

Open Access

Long-Term Outcome of Adjunctive Celecoxib Treatment After Paclitaxel-Eluting Stent Implantation for the Complex Coronary Lesions

Author(s) -

Jin-Wook Chung,

HanMo Yang,

Kyung Woo Park,

HaeYoung Lee,

JinShik Park,

HyunJae Kang,

YoungSeok Cho,

TaeJin Youn,

BonKwon Koo,

InHo Chae,

DongJu Choi,

ByungHee Oh,

Young-Bae Park,

Hyo-Soo Kim

Publication year - 2010

Publication title -

circulation cardiovascular interventions

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.621

H-Index - 95

eISSN - 1941-7632

pISSN - 1941-7640

DOI - 10.1161/circinterventions.109.889881

Subject(s) - celecoxib , medicine , myocardial infarction , adverse effect , clopidogrel , aspirin , paclitaxel , cardiology , revascularization , restenosis , randomized controlled trial , adjunctive treatment , anesthesia , stent , surgery , cancer

In the COREA-TAXUS trial ("Effect of Celecoxib On REstenosis after coronary Angioplasty with a TAXUS stent"), celecoxib reduced late luminal loss and adverse cardiac events at follow-up around 6 months. The objective of this study was to assess the long-term outcome of short-term adjunctive celecoxib treatment after paclitaxel-eluting stent implantation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research